All In Biotech

Drug Trial Radar · NCT07502001

Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin

A Phase I, Single-center, Open-Label, Single-Arm, Fixed-Sequence Study to Evaluate the Influence of HDM1005 on Gastric Emptying and Drug-Drug Interaction of HDM1005 and Metformin, Atorvastatin, Warfarin, and Digoxin in Overweight/Obese Adult Chinese Subjects

Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Apr 8, 2026

Primary completion

Dec 1, 2026

Study completion Jun 2, 2027

Sponsor

Sponsor type
Industry
First posted
Mar 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to characterize the Influence of HDM1005 on gastric emptying and drug-drug interaction of HDM1005 and metformin, atorvastatin, warfarin, and digoxin in overweight/obese adult subjects.

Conditions

  • Overweight
  • Obesity

Interventions

  • AcetaminophenDrug

    Single dose; Administered orally

  • MetforminDrug

    Single dose; Administered orally

  • WarfarinDrug

    Single dose; Administered orally

  • AtorvastatinDrug

    Single dose; Administered orally

  • DigoxinDrug

    Single dose; Administered orally

  • HDM1005 injectionDrug

    Subcutaneous injection QW

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Concentration Time Curve From Time Zero to ∞ [ AUC(0- ∞)]Time frame: Up to Day 115
  2. Maximum observed concentration (Cmax)Time frame: Up to Day 115
  3. Area Under the Concentration Time Curve From Time Zero to t [ AUC(0- t)]Time frame: Up to Day 115
  4. Time of maximum observed concentration (Tmax)Time frame: Up to Day 115

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.